We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+14.92%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$3.83B
AUM Growth
+$434M
Cap. Flow
-$11.3M
Cap. Flow %
-0.29%
Top 10 Hldgs %
18.08%
Holding
254
New
3
Increased
88
Reduced
34
Closed
13

Sector Composition

Rank Sector Weight
1 Technology 34.44%
2 Industrials 16.35%
3 Healthcare 15.87%
4 Consumer Discretionary 10.58%
5 Financials 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORLY icon
101
O'Reilly Automotive
ORLY
$73.5B
$11.9M 0.31%
396,000
EW icon
102
Edwards Lifesciences
EW
$51.2B
$11.9M 0.31%
130,000
-6,000
-4% -$498K
DPZ icon
103
Domino's
DPZ
$11.9B
$11.6M 0.3%
30,300
SPSC icon
104
SPS Commerce
SPSC
$2.77B
$11.3M 0.3%
104,500
STZ icon
105
Constellation Brands
STZ
$22.4B
$11.2M 0.29%
51,000
DG icon
106
Dollar General
DG
$28.2B
$10.7M 0.28%
51,105
+5
+0% +$1.07K
ADP icon
107
Automatic Data Processing
ADP
$108B
$10.6M 0.28%
59,900
-93,900
-61% -$15.4M
FANG icon
108
Diamondback Energy
FANG
$56B
$10.2M 0.27%
210,000
-20,000
-9% -$740K
MU icon
109
Micron Technology
MU
$933B
$10.2M 0.27%
135,098
-34,902
-21% -$2.1M
PLAN
110
DELISTED
Anaplan, Inc.
PLAN
$10M 0.26%
139,649
+20,000
+17% +$1.3M
COUP
111
DELISTED
Coupa Software Incorporated
COUP
$10M 0.26%
29,503
+13,003
+79% +$4.02M
GPN icon
112
Global Payments
GPN
$23.4B
$9.89M 0.26%
45,896
+10,009
+28% +$1.87M
BMY icon
113
Bristol-Myers Squibb
BMY
$133B
$9.62M 0.25%
155,078
-19,922
-11% -$1.23M
LEN icon
114
Lennar Class A
LEN
$20.3B
$9.53M 0.25%
129,171
+48,597
+60% +$3.64M
JPM icon
115
JPMorgan Chase
JPM
$935B
$9.53M 0.25%
75,000
+5,000
+7% +$559K
CSGP icon
116
CoStar Group
CSGP
$12.2B
$9.52M 0.25%
103,040
+40
+0% +$3.51K
SF
117
Stifel
SF
$12.5B
$9.47M 0.25%
281,475
RBC icon
118
RBC Bearings
RBC
$18B
$9.4M 0.25%
52,500
BAC icon
119
Bank of America
BAC
$435B
$9.4M 0.25%
310,076
-9,924
-3% -$266K
USPH icon
120
US Physical Therapy
USPH
$1.21B
$9.36M 0.24%
77,800
COO icon
121
Cooper Companies
COO
$14.4B
$8.97M 0.23%
98,800
ICPT
122
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$8.28M 0.22%
335,000
+184,000
+122% +$6.1M
PLUS icon
123
ePlus
PLUS
$2.47B
$8.26M 0.22%
187,800
EVBG
124
DELISTED
Everbridge, Inc. Common Stock
EVBG
$8.15M 0.21%
54,700
BIO icon
125
Bio-Rad Laboratories Class A
BIO
$8.91B
$7.94M 0.21%
13,619
+19
+0.1% +$10.8K

Similar funds

EULAV Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, EULAV Asset Management held 254 positions worth $3.83B, up 13% from $3.39B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

EULAV Asset Management's Q4 2020 filing shows 3 new, 88 increased, 34 reduced and 13 closed positions. Its largest new stake was Global Blood Therapeutics, Inc.: 320,000 shares worth $13.9M. The largest sale was Accenture, an estimated $19.9M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 34% a quarter earlier, followed by Industrials and Healthcare.

  • EULAV Asset Management's largest Q4 2020 buy was Global Blood Therapeutics, Inc.: 320,000 shares worth $13.9M.
  • EULAV Asset Management added most to Exelixis in Q4 2020, an estimated $10.7M increase.
  • EULAV Asset Management's biggest Q4 2020 reduction was Accenture, cutting an estimated $19.9M.
  • EULAV Asset Management fully exited Slack Technologies, Inc. in Q4 2020, selling an estimated $13.7M.
  • EULAV Asset Management's ten largest holdings make up 18% of its $3.83B portfolio in Q4 2020.
  • EULAV Asset Management opened 3 new positions and closed 13 in Q4 2020.
  • EULAV Asset Management's portfolio value rose 13% quarter-over-quarter to $3.83B.

Based on EULAV Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.